Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2830687 | HLA-DR (HLA-DR) | hepatitis c | NA | NA | NA | unclassified | |
| cytomegalovirus hepatitis caused class i and hla-dr induction on hepatocytes | |||||||
| 2830687 | HLA-DR (HLA-DR) | cholangitis | NA | NA | NA | unclassified | |
| cytomegalovirus hepatitis caused class i and hla-dr induction on hepatocytes | |||||||
| 2840670 | HLA-A (HLA-A) | transplantation | NA | NA | NA | unclassified | |
| the human major histocompatibility complex encodes three classical class i antigens, hla-a, -b, and -c. of these hla-a and -b act as strong transplantation antigens and as restriction molecules for recognition of foreign antigen by cytotoxic t lymphocytes. | |||||||
| 2840670 | HLA-C*03 | influenza | NA | NA | NA | unclassified | |
| functional studies demonstrated that transgenic skin was rapidly rejected by normal c57bl/6 mice and that cytotoxic t lymphocytes generated by immunization of the cw3 transgenic mice with influenza and sendai virus were restricted by the cw3 molecule. | |||||||
| 2860919 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | methotrexate | NA | unclassified | |
| NA | |||||||
| 2860919 | HLA IDENTICAL (HLA-IDENTICAL) | cyclophosphamide | NA | methotrexate | NA | negation | |
| NA | |||||||
| 2866386 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | prednisone | NA | negation | |
| grafts were not hla-matched, and the mean interval between completion of tli and transplantation was 9 days. | |||||||
| 2877223 | HLA MISMATCHED (HLA-MISMATCHED) | transplantation | NA | cyclophosphamide | NA | unclassified | |
| prevention of graft failure by an anti-hlfa-1 monoclonal antibody in hla-mismatched bone-marrow transplantation. | |||||||
| 2882184 | HLA MATCHED (HLA-MATCHED) | transplantation | NA | NA | NA | unclassified | |
| to study the importance of transferred immunity against cytomegalovirus (cmv) in allogeneic, hla-matched, t-cell-depleted bone-marrow transplantation, the incidence, severity, and outcome of cmv infections were studied in 40 cmv-seropositive recipients in relation to the donors' immunity against cmv. | |||||||
| 2882184 | HLA MATCHED (HLA-MATCHED) | infections | NA | NA | NA | unclassified | |
| to study the importance of transferred immunity against cytomegalovirus (cmv) in allogeneic, hla-matched, t-cell-depleted bone-marrow transplantation, the incidence, severity, and outcome of cmv infections were studied in 40 cmv-seropositive recipients in relation to the donors' immunity against cmv. | |||||||
Copyright 2024